Evaluation of Recurrence Risk in Irreversible Electroporation-Treated Pancreatic Adenocarcinoma Patients Using Radiomics Signatures.
Saved in:
| Title: | Evaluation of Recurrence Risk in Irreversible Electroporation-Treated Pancreatic Adenocarcinoma Patients Using Radiomics Signatures. |
|---|---|
| Authors: | Gordon JWH; Tempus AI, Chicago, IL 60654, USA., Goel A; Tempus AI, Chicago, IL 60654, USA., Martin RCG 2nd; Division of Surgical Oncology, Department of Surgery, University of Louisville, Louisville, KY 40202, USA. |
| Source: | Cancers [Cancers (Basel)] 2025 Jul 15; Vol. 17 (14). Date of Electronic Publication: 2025 Jul 15. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2072-6694 |
|---|---|
| DOI: | 10.3390/cancers17142338 |
